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Abstract 
Revised U.S. guidelines for cervical cancer screening provide the option of primary human papillomavirus 
(HPV) testing, Pap testing, or co-testing. Primary HPV testing has not yet been an option for American 
women, and women may be reluctant to change screening methods. The purpose of this study was to 
assess correlates of women’s preferences for primary HPV testing decision-making (self, provider, or 
shared) for cervical cancer screening. Women, aged 30-65, completed an online survey in June of 2018 (n 
= 812). The outcome variable was preference for decision-making for an HPV test instead of a Pap test 
on a scale of, healthcare provider, me, or shared. Predictor variables included testing attitudes, social 
norms, information seeking, previous screening, and socio-demographics. Women who disagreed that 
people important to them think that they should get the HPV test instead of a Pap test, who were not 
willing to receive an HPV test instead of a Pap test, and who did not receive HPV vaccinations were less 
likely to include a provider in their decision-making. In contrast, women who were not up-to-date with their 
cervical cancer screenings, who had some college or technical level education, or who were over 50 years 
of age were more likely to prefer to have a healthcare provider included in their decision-making process. 
While some variation was discovered, women mostly preferred a shared decision or personal decision for 
HPV testing. Resources to facilitate the decision-making process about this new option for cervical 
cancer screening are needed. 
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Abstract 
Revised U.S. guidelines for cervical cancer screening provide the option of primary human 
papillomavirus (HPV) testing, Pap testing, or co-testing. Primary HPV testing has not yet been an 
option for American women, and women may be reluctant to change screening methods. The 
purpose of this study was to assess correlates of women’s preferences for primary HPV testing 
decision-making (self, provider, or shared) for cervical cancer screening. Women, aged 30-65, 
completed an online survey in June of 2018 (n = 812). The outcome variable was preference for 
decision-making for an HPV test instead of a Pap test on a scale of, healthcare provider, me, or 
shared. Predictor variables included testing attitudes, social norms, information seeking, previous 
screening, and socio-demographics. Women who disagreed that people important to them think 
that they should get the HPV test instead of a Pap test, who were not willing to receive an HPV 
test instead of a Pap test, and who did not receive HPV vaccinations were less likely to include a 
provider in their decision-making. In contrast, women who were not up-to-date with their cervical 
cancer screenings, who had some college or technical level education, or who were over 50 years 
of age were more likely to prefer to have a healthcare provider included in their decision-making 
process. While some variation was discovered, women mostly preferred a shared decision or 
personal decision for HPV testing. Resources to facilitate the decision-making process about this 
new option for cervical cancer screening are needed.  
 




Human papillomavirus (HPV) causes 
virtually all cases of cervical cancer 
(Walboomers et al., 1999). While cervical 
cancer was previously the leading cause of 
cancer death among women in the United 
States (U.S.), screening has reduced these 
rates dramatically. In 2017, 12,831 cervical 
cancer cases were reported in the U.S., and 
4,207 deaths due to cervical cancer occurred; 
rates were higher among black and Hispanic 
women compared to white women (U.S. 
Cancer Statistics Working Group, 2020). The 
majority of cervical cancer cases are 
attributed to lack of screening among women 
by failing to identify pre-cancers before they 
develop into cervical cancer (Melnikow et 
al., 2018), and current cervical cancer 
screening data indicate 81% of women in the 
U.S. are up-to-date on screening (National 
Cancer Institute, 2020). In order to eliminate 
cervical cancer in the U.S., increasing 
screening to 90% can speed up this goal 
(Burger et al., 2020). 
In 2018, the U.S. Preventive Services 
Task Force revised the recommendations for 
cervical cancer screening to provide the 
option of primary HPV testing every five 
years among women 30-65 years of age. 
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Women in this age group also have the option 
of Pap testing every three years or co-testing 
(Pap testing plus HPV testing) every five 
years. The rationale for providing the option 
of primary HPV testing is due to the 
improved sensitivity of the test and improved 
cost-effectiveness due to wider screening 
intervals (Curry et al., 2018).  
While studies indicate many U.S. women 
report primary HPV testing as acceptable, 
women may find HPV testing less acceptable 
when they have negative attitudes about 
delayed screening intervals, are married, and 
have negative emotions related to HPV 
testing (Tatar et al., 2018). Similarly, some 
countries have faced resistance when cervical 
cancer screening programs transitioned 
completely to primary HPV testing rather 
than a Pap test (Chrysostomou et al., 2018). 
This may be attributed to confusion regarding 
what a Pap test actually screens (Daley et al., 
2010; Perrin et al., 2006). Additionally, 
healthcare providers may be unprepared for 
this guideline transition, which may be 
attributed to concerns about interval length 
for screening, concerns about patients’ 
reactions to HPV testing being a sexually 
transmitted infection test, and variation in 
following guidelines by clinics (Head et al., 
2020; Tatar et al., 2019).  
According to the U.S. Community Guide, 
one-on-one counseling is recommended for 
healthcare providers and patients to promote 
cervical cancer screening (Community 
Preventive Services Task Force, 2012). In 
order to promote cervical cancer screening in 
the midst of this guideline transition with the 
option of HPV-only testing, there is a need to 
explore the screening decision-making role 
preferences of women with different health 
histories, sociodemographic backgrounds, 
attitudes, and knowledge levels. This study 
explored women’s preferences for decision-
making for HPV testing instead of Pap 
testing; specifically, making the decision 
themselves, a shared decision with their 
provider, or relying on a provider to make the 
decision. Findings from this study can inform 
counseling strategies healthcare providers 
utilize with their patients in order to promote 






The target population for this study was 
women who are eligible for receiving HPV 
testing according to the recent guideline’s 
recommendations: 30-65 years of age, 
without the history of hysterectomy. The 
recruitment of participants was conducted 
through the Qualtrics Online Panel, and 
African American and Hispanic women were 
oversampled due to the higher burden of 
cervical cancer among these populations 
(U.S. Cancer Statistics Working Group, 
2020). Research panel members were invited 
to participate in the survey. Eligible women 
participated in the survey after providing 
informed consent presented at the beginning 
of the survey. Data were collected in June of 
2018 with a sample size of 812 participants. 
The study was approved with an exempt 
status by the North Texas Regional 




The outcome variable, using a scaled 
measure, assessed the decision-making role 
preference of the participant and asked, 
“Whether I would have an HPV test instead 
of a Pap test would be entirely up to...” The 
participant then had the option of choosing a 
number on a sliding scale ranging from 1 to 
100 with lower values indicating independent 
decision-making, moderate range values 
indicating a preference for shared decision 
making with the provider, and higher values 
indicating a preference for the healthcare 
2





provider to make the decision. This variable 
was used as a continuous variable. 
The predictor variables included 
sociodemographic factors and variables that 
have previously been found to have an 
association with the cervical cancer screening 
decision-making preferences of an individual 
(Tatar et al., 2018). Sociodemographic 
variables included age (30-50 years, ≥ 50 
years), highest educational level attained 
(high school or less, some college/technical, 
4 years of college or higher), race (white, 
black, others), and ethnicity (non-Hispanic, 
Hispanic).  
HPV knowledge was assessed by utilizing 
a validated 16-item knowledge scale by Perez 
and colleagues (Perez et al., 2016). In 
response to 16 HPV-related statements, 
participants responded “True,” “False,” or 
“Don’t Know.” Correct responses were 
assigned a point, and all correct points were 
summed and averaged, with higher scores 
indicating increased HPV knowledge. The 
Cronbach’s alpha for this sample was 0.89. 
For HPV testing awareness, the study asked, 
“Have you ever heard of HPV testing?” 
(“Yes,” “No,” and “Don’t know”). 
Participants who responded “No” and “Don’t 
know” were recoded into a “No” category. 
Ease of finding and understanding cervical 
cancer information used questions from the 
European Health Literacy Survey 
Questionnaire (HLS-EU-Q), adapted 
specifically for cervical cancer information 
(Sørensen et al., 2013). When asked “How 
easy is it for you to find information on 
cervical cancer screening?” and “How easy is 
it for you to understand information on 
cervical cancer screening?”, response options 
included very easy, easy, somewhat easy, and 
not easy. Due to response distribution, 
responses of somewhat easy and not easy 
were collapsed into a single category. 
HPV testing attitudes, subjective norms, 
and provider recommendation were also 
assessed. An HPV testing attitude scale 
adapted from Ogilvie and colleges (Ogilvie et 
al., 2013) was assessed: “Having an HPV test 
to screen for cervical cancer every 5 years 
and after age 30 instead of a Pap smear every 
3 years would be: accurate/safe/protect my 
health/acceptable.” Response options 
ranging from strongly agree to strongly 
disagree were aggregated to produce a sum 
score (α = 0.946). Ogilvie and colleagues’ 
(Ogilvie et al., 2013) subjective norms 
question was also adapted: “If national 
guidelines recommended having an HPV test 
to screen for cervical cancer instead of a Pap 
smear, most people who are important to me 
would think I should/expect me to have an 
HPV test instead of a Pap smear.” Due to the 
bimodal distribution of the variable, the 
seven responses were recoded into three 
categories: “Agree” (“Strongly agree,” 
“Agree,” and “Somewhat agree”); “Neither 
agree nor disagree”; and “Disagree” 
(“Strongly disagree,” “Disagree,” and 
“Somewhat disagree”). Whether the 
participant agreed to have HPV testing 
instead of Pap testing based on a healthcare 
provider’s recommendation was assessed, 
with responses of “Yes,” “No,” or “Don’t 
know.” (Saraiya et al., 2018) “No” and 
“Don’t know” responses were re-coded as 
“No.” 
Relevant health history (i.e., screening up-
to-date, HPV vaccination, and non-HPV 
sexually transmitted infection diagnosis 
history) was also assessed. Up-to-date with 
2018 cervical cancer screening guidelines 
status was determined with two questions: 
“How long ago did you have your most recent 
Pap test?” (from the Health Information 
National Trends Survey), and “An HPV test 
is sometimes given with the Pap test for 
cervical cancer screening. Did you have an 
HPV test with your most recent Pap?” (from 
the 2014 National Health Interview Survey). 
If the participant reported having a Pap test 
within the last three years or an HPV test with 
their last Pap test within 5 years, the 
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participant was up-to-date. Otherwise, the 
participant was not up-to-date. History of any 
HPV vaccination was assessed, with 
responses of “Yes,” “No,” and “Don’t 
know.”  History of a sexually transmitted 
infection diagnosis other than HPV was also 
assessed with responses of “Yes,” “No,” and 
“Don’t know,” recoding “No” and “Don’t 




We conducted the univariate and bivariate 
analysis for the continuous outcome variable 
assessing the shared decision-making 
preference. Multiple linear regression was 
used to identify the predictor variables 
independently associated with decision-
making preference. The multiple linear 
regression model was significant and 
accounted for 8.7% of the variance with F(20, 
791) = 3.79, p < 0.01. The assumptions for 
the model were tested and all the assumptions 
were met. All the variables that are 
considered essential for health-related 
decision-making were entered in the model 
together. Adjusted regression coefficients 
and p-values were reported. The analysis was 




Among the 812 women surveyed, 63% 
were between 30 to 50 years old, 68% of the 
women were white, 23% were black, and 9% 





Demographic and Health Behavior Characteristics of Sample (n = 812) 
Variable         n (%) 
Decision-Making (mean (SD))a 44.67 (32.31) 
Attitude Towards HPV Test (mean (SD))b 20.86 (5.49) 
HPV Knowledge Score (mean (SD))c 8.10 (4.58) 
People Important to Me Think I Should Have HPV Test Instead of Pap 
Test  
Agree 445 (54.80) 
Neither Agree nor Disagree 303 (37.32) 
Disagree 64 (7.88) 
Up-to-Date with Cervical Cancer Screening  
Up-to-Date  580 (71.43) 
Not Up-to-Date 232 (28.57) 
Agree to Have HPV Test Instead of Pap Test on Doctor's 
Recommendation  
Yes 505 (62.19) 
No 307 (37.81) 
Ease of Finding Cervical Cancer Screening Information  
Very Easy 341 (42.00) 
Easy 289 (35.59) 
Somewhat/Not Easy 182 (22.41) 
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Table 1 (continued) 
 
Demographic and Health Behavior Characteristics of Sample (n = 812) 
Variable              n (%) 
Ease of Understanding Cervical Cancer Screening Information  
Very Easy 303 (37.32) 
Easy 285 (35.10) 
Somewhat/Not Easy 224 (27.59) 
Education  
Less than High School/High School 270 (33.25) 
Some College/Technical 296 (36.45) 
College 246 (30.30) 
Age  
< 50 years 514 (63.30) 
≥ 50 years 298 (36.70) 
Race  
White 553 (68.10) 
Black 187 (23.03) 
Other Race, including Bi/Multiracial 72 (8.87) 
Ethnicity  
Non-Hispanic 661 (81.40) 
Hispanic 151 (18.60) 
Heard of HPV Testing  
Yes  507 (62.44) 
No/Don't Know 305 (37.56) 
Received HPV Vaccination  
Yes 100 (12.32) 
No 592 (72.91) 
Don't Know 120 (14.78) 
Ever Had a Sexually Transmitted Infection Other than HPV  
Yes 135 (16.63) 
No/Don't Know 677 (83.37) 
Note. aDecision-making scale: 1 to 100; bAttitudes scale: 4 to 28; cKnowledge scale: 0 to 16 
 
 
Most of the women had some college or 
technical school education (36%). The mean 
decision-making score was 44.7 (SD = 32.3), 
indicating that more women preferred shared 
decision-making with their healthcare 
provider (Figure 1). Nearly two-thirds (62%) 
of the women had heard of HPV testing 
before, and only 12% of the women had ever 
received HPV vaccination. The mean score 
for attitude towards HPV testing was 20.9 
(SD = 5.5), with a range between 4 and 28, 
suggesting that more women agreed that 
HPV testing is safe, accurate, acceptable, and 
protected their health. The mean HPV 
knowledge score was 8.1 (SD = 4.6) out of 
16, which shows that women had relatively 
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low knowledge regarding HPV. Most women 
agreed that people important to them think 
they should get an HPV test instead of a Pap 
test (55%), and they would be willing to get 
an HPV test instead of a Pap test on their 
doctor’s recommendation (62%). More than 
two-thirds (71%) of the women were up-to-
date with their cervical cancer screening. 
Most of the women considered it was very 
easy or easy to find (78%) and understand 
(72%) cervical cancer screening information. 
Table 2 presents the coefficients from the 
adjusted linear regression model. After 
controlling for other variables, women who 
disagreed with the statement that people who 
are important to them think that they should 
get HPV test instead of Pap test were less 
likely to prefer their provider to decide for 
them (b = -11.03). Women who did not agree 
to receiving an HPV test instead of a Pap test 
were more likely to make the decision 
independently (b = -7.50). Women who had 
some college or technical level education (b 
= -6.18) or who were over 50 years old (b = -
5.13) were more likely to make the decision 
independently. Women who did not receive 
HPV vaccination were less likely to include 
healthcare provider in their decision-making 
(b = -8.70). Women who were not up-to-date 
with cervical cancer screening were more 
likely to prefer their provider to make a 
decision (b = 5.27). Furthermore, women 
from non-white or non-black identified races 
were more likely to prefer a healthcare 
provider to be involved in decision-making 




With the recent option of primary HPV 
testing as a mode for cervical cancer 
screening in the United States, understanding 
women’s preferences for deciding on primary 
HPV testing can inform strategies that 
increase screening for the elimination of 
cervical cancer. Perhaps most important, this 
study found women preferred an individual 
decision-making approach and that decision-
making preferences were influenced by 





Figure 1. Distribution of the decision-making score for HPV testing (n = 812). 
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Adjusted Linear Regression Model of HPV Testing Decision-making Preference among 





Coefficientsa (SE) p-value 
Attitude Towards HPV Test  0.07 (0.24) 0.75 
HPV Knowledge Score   
People Important to Me Think I Should Have HPV Test 
Instead of Pap Test   
Agree Ref  
Neither Agree nor Disagree -1.81 (2.62) 0.49 
Disagree -11.03 (4.65) 0.02 
Up-to-Date with Cervical Cancer Screening   
Up-to-Date Ref  
Not Up-to Date 5.27 (2.59) 0.04 
Agree to Have HPV Test Instead of Pap Test on Doctor's 
Recommendation   
Yes Ref  
No -7.50 (2.57) <0.01 
Ease of Finding Cervical Cancer Screening Information   
Very Easy 3.19 (3.89) 0.41 
Easy 2.04 (3.51) 0.56 
Somewhat/Not Easy Ref  
Ease of Understanding Cervical Cancer Screening 
Information   
Very Easy 1.29 (3.67) 0.73 
Easy 0.67 (3.28) 0.84 
Somewhat/Not Easy Ref  
Education   
Less than High School/High School Ref  
Some College/Technical -6.18 (2.72) 0.02 
College -1.55 (2.94) 0.60 
Age   
< 50 years Ref  
≥ 50 years -5.13 (2.43) 0.04 
Race   
White Ref  
Black 3.68 (2.78) 0.19 
Other Race, including Bi/Multiracial 10.67 (4.09) 0.01 
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Adjusted Linear Regression Model of HPV Testing Decision-making Preference among 





Coefficientsa (SE) p-value 
Ethnicity   
Non-Hispanic Ref  
Hispanic -2.96 (3.10) 0.33 
Heard of HPV Testing   
Yes  Ref  
No/Don't Know 3.39 (2.70) 0.21 
Received HPV Vaccination   
Yes Ref  
No -8.70 (3.56) 0.01 
Don't Know -1.47 (4.48) 0.74 
Ever Had a Sexually Transmitted Infection Other than 
HPV   
Yes Ref  
No/Don't Know 1.41 (3.05) 0.64 
Note. aunstandardized   
 
Below, we discuss the findings of this study 
and highlight implications for clinical 
practice and future work.  
The majority of women in this study 
indicated that they strongly preferred an 
individual or shared decision-making 
approach, with the lowest being a preference 
for provider-only decision.  These findings 
are consistent with a shared decision-making 
approach, which “rests on accepting that 
individual self-determination is a desirable 
goal and that clinicians need to support 
patients to achieve this goal” (Elwyn et al., 
2012). As the United States considers moving 
toward HPV testing for cervical cancer 
screening, incorporating shared decision-
making strategies into the one-on-one 
counseling of patients considering HPV-only 
testing is imperative.   
To incorporate shared decision-making 
for HPV testing, clinicians should consider 
providing information to women regarding 
HPV testing and presenting the options, 
intervals, risks, and benefits, so women can 
make an informed decision for their needs. 
Additionally, it has been noted that 
guidelines and recommendations for 
screening do not often address women’s 
preferences or values and do not provide 
specific recommendations for providers to 
discuss (Sawaya & Kuppermann, 2015). 
Studies on cervical cancer screening have 
noted that women wanted to be 
knowledgeable enough to weigh their options 
and choose an option for them based on their 
values, but women also wanted input from 
their providers (Wood et al., 2018). 
Healthcare  providers  report taking paternal- 
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istic approaches when discussing options, as 
they wanted women to have the autonomy to 
make decisions but remain within the context 
of the evidence-based recommendations 
(Wood et al., 2018). In these situations, 
women may find it difficult to act on their 
preferred decision if it does not align with 
their provider’s preferred decision, reducing 
the amount of autonomy women are able to 
exert over their screening (Adams et al., 
2012). Furthermore, when discussing cancer 
screening decisions with providers, patients 
report that these discussions mostly focused 
on the pros of screening and less often 
included a focus on the potential cons 
(Hoffman et al., 2010). Instead, it is 
imperative that any shared decision-making 
approach reflects the idea that the provider’s 
role is to “be a navigator, not a pilot” by 
ensuring that patients are using relevant and 
accurate information in their decision-
making and that they understand the 
ramifications of their choice (McNutt, 2004). 
Exploring providers’ perceptions of shared 
decision-making for HPV testing may shed 
light on empowering communication 
approaches to utilize during these 
discussions, as people who are involved in 
decision-making regarding their health report 
better health outcomes (Hibbard & Greene, 
2013; Hoffmann et al., 2014). Further 
research is needed to determine whether 
these findings hold true with HPV testing. 
Just 12% of this sample reported ever 
receiving the HPV vaccine, and women who 
had not been vaccinated for HPV were more 
likely to prefer making a personal decision 
for HPV testing, compared to those who were 
vaccinated. Almost half of providers in one 
study said that patient HPV vaccine status 
influenced their cervical cancer screening 
practices (Cooper & Saraiya, 2017). Receipt 
of the HPV vaccine has been associated with 
higher rates of screening adherence (Chao et 
al., 2017). In the HPV testing 
recommendation from the U.S. Preventive 
Services Task Force, many screening 
approaches and intervals are presented 
(United States Preventive Services Task 
Force, 2018). Given these options, the 
Community Preventive Services Task Force 
recommends the use of patient-provider 
communication with a goal of “informing, 
encouraging, and motivating” patients to 
seek cervical cancer screening (Community 
Preventive Services Task Force, 2020), 
strengthening the argument to consider a 
shared decision-making approach to HPV 
testing. Specifically, women who have not 
received the vaccine may mistrust providers 
and the healthcare system and have difficulty 
talking to their providers (Kolar et al., 2015), 
therefore opting to prefer an individual 
decision about screening. Tailored materials 
and counseling strategies addressing this 
mistrust may improve patient-provider 
communication and facilitate shared 
decision-making for cervical cancer 
screening, as women were more confident in 
their decision-making without provider 
influence if they were informed (Wood et al., 
2018). 
Women who attended some college, 
compared to women with high school or less 
education, were more likely to prefer to make 
the decision themselves about HPV 
screening. There were no differences, 
however, between women who completed 
college and those with a high school or less 
education for decision-making preferences. 
Similarly, previous studies have found 
variation in HPV and cervical cancer 
knowledge and HPV testing acceptability 
based of educational attainment (Thompson 
et al., 2018). In contrast, women who are not 
white or black were more likely to prefer that 
a healthcare provider be involved in the 
decision-making; however, disentangling the 
heterogeneity within the “other” racial group 
may identify different patterns among 
specific groups of women. Future studies 
should explore the socio-cultural differences 
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in cervical cancer screening decision-making 
among women and how these differences 
may inform prevention programming. 
Findings must be considered in light of a 
few limitations. As a cross-sectional study, 
generalizations regarding the temporality of 
associations cannot be determined based on 
this study alone. Additionally, since the data 
were collected via Qualtrics Online Panels, 
generalizability is limited. U.S. participants 
in online survey panel studies have been 
shown to be less diverse compared to studies 
with clinical samples, based on racial and 
ethnic disparities in language, Internet 
access, and frequency of survey participation 
(Grov et al., 2016; Ibarra et al., 2018). 
Utilizing quota sampling to account for more 
black and Hispanic women partially 
addressed this limitation, but women who did 
not speak English were excluded from the 
sample. Moreover, data were reported via 
self-report, which may result in less 
reliability in reporting screening behaviors 
when compared to utilizing medical record 
data (Anderson et al., 2019). Providing 
educational content within the survey 
regarding guideline recommendations and 
explanations of HPV tests and Pap tests 
mitigated some recall bias. Finally, the 
question for assessing preference for a 
decision was on a large, zero-to-100 scale and 
had significant variability. Future studies 
may consider utilizing a fixed response 
option for this type of question. 
 
Implications for Health Behavior Theory 
 
This study examined women’s 
preferences for an individual, shared, or 
provider-based decision for HPV testing 
compared to Pap testing. With this new 
transition in recommended guidelines for 
cervical cancer screening, recognizing 
women’s preferences is needed for patient-
centered programming to improve cervical 
cancer screening rates. Ultimately, im-
proving cervical cancer screening, par-
ticularly among under-screened women, has 
the potential to contribute to the overall goal 
of eliminating cervical cancer in the United 
States. 
In order to successfully implement 
primary HPV testing as a mode of cervical 
cancer screening, the preferences of women 
need to be recognized for shared decision-
making. Variation in preferences exist for 
women spanning from individual decision, a 
shared decision, and a provider –based 
decision. Providers should incorporate 
women’s preferences when providing one-





What are strategies to involve women in the 
decision-making process for transitioning to 
HPV testing instead of Pap testing for 
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